Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MGAM | O43451 | 1/20 | 0.34 |
| ▸ | SI | P14410 | 1/20 | 0.34 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8532180 | 0.88 | POLB (0.40) | POLBALDH1A1TSHRCYP3A4CYP2C9 | |
| SCHEMBL5100575 | 0.86 | CYP3A4 (0.41) | POLBTSHRCYP3A4CYP2C9CYP2C19 | |
| SCHEMBL6507073 | 0.84 | POLB (0.34) | POLBALDH1A1TSHRCYP3A4CYP2C9 | |
| SCHEMBL14524858 | 0.84 | POLB (0.38) | POLBALDH1A1TSHRCYP3A4CYP2C9 | |
| SCHEMBL1051880 | 0.84 | POLB (0.53) | POLBALDH1A1TSHRCYP3A4CYP2C9 | |
| SCHEMBL1594230 | 0.83 | ALDH1A1 (0.42) | POLBALDH1A1TSHRCYP3A4CYP2C9 | |
| SCHEMBL6922463 | 0.82 | GAA (0.40) | POLBALDH1A1TSHRCYP3A4CYP2C9 | |
| SCHEMBL7216304 | 0.82 | ALDH1A1 (0.43) | POLBALDH1A1TSHRCYP3A4CYP2C9 | |
| SCHEMBL10788776 | 0.82 | POLB (0.37) | POLBALDH1A1TSHRCYP3A4CYP2C9 | |
| SCHEMBL9461450 | 0.82 | ALDH1A1 (0.54) | POLBALDH1A1TSHRCYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 449 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122080573-A | Flame-retardant phenolic aldehyde/glass fiber composite board, preparation method and application | — | 2026-05-26 | — | — | CN | claimed |
| CN-119431361-A | Preparation method of PARP1 inhibitor | 上海喀露蓝科技有限公司 | 2025-02-14 | — | — | CN | claimed |
| US-8574757-B2 | Nonaqueous electrolytic solution and nonaqueous electrolyte battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-11-05 | — | — | US | claimed |
| US-20120264011-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-10-18 | — | — | US | claimed |
| CN-122080573-A | Flame-retardant phenolic aldehyde/glass fiber composite board, preparation method and application | — | 2026-05-26 | — | — | CN | disclosed |
| US-12606555-B2 | Chemical compounds | ASTRAZENECA AB (SE) | 2026-04-21 | — | — | US | disclosed |
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS PBC (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260055104-A1 | CRYSTAL FORM OF HETEROARYL DERIVATIVE PARP INHIBITOR AND USE THEREOF | HAISCO PHARMACEUTICAL GROUP CO LTD (CN) | 2026-02-26 | — | — | US | disclosed |
| US-20260027108-A1 | PHARMACEUTICAL COMPOSITION OF HETEROARYL DERIVATIVE AND MEDICAL USE THEREOF | HAISCO PHARMACEUTICAL GROUP CO LTD (CN) | 2026-01-29 | — | — | US | disclosed |
| US-20260007672-A1 | INHIBITORS OF MPTP | NRG THERAPEUTICS LTD (GB) | 2026-01-08 | — | — | US | disclosed |
| US-12491185-B2 | Inhibitors of mPTP | NRG THERAPEUTICS LTD (GB) | 2025-12-09 | — | — | US | disclosed |
| EP-4652161-A1 | 2,4-DIANILINOPYRIMIDINE-BASED AURORA-A KINASE SELECTIVE DEGRADATION INDUCING COMPOUNDS | Uppthera, Inc. (KR) | 2025-11-26 | — | — | EP | disclosed |
| US-4534979-A | Polyene compounds useful in the treatment of psoriasis and allergic responses | USV PHARMACEUTICAL CORP. (US) | 1985-08-13 | — | — | US | disclosed |
| US-4505930-A | Alpha-alkyl polyolefinic carboxylic acids and derivatives thereof useful in the treatment of psoriasis and allergic responses | USV PHARMACEUTICAL CORPORATION (US) | 1985-03-19 | — | — | US | disclosed |
| EP-0113106-A1 | New nitro aliphatic compounds, process for preparation thereof and use thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-07-11 | — | — | EP | disclosed |
| US-4427682-A | ANTICOAGULANTS, ANTIINFLAMMATORY, HYPOTENSIVE, OR ANTIALLERGEN AGENTS | ONO PHARMACEUTICAL CO., LTD. (JP) | 1984-01-24 | — | — | US | disclosed |
| US-4317828-A | ANTIINFLAMMATORY AGENTS, HYPOTENSIVE AGENTS | ONO PHARMACEUTICAL CO., LTD. (JP) | 1982-03-02 | — | — | US | disclosed |
| US-4271170-A | THROMBOXANE SYNTHETASE ENZYME INHIBITOR USEFUL IN TREATING INFLAMMATION, HYPERTENSION, THROMBUS, CEREBRAL APOPLEXY, ASTHMA, AND CARDIOVASCULAR DISORDERS | ONO PHARMACEUTICAL CO., LTD., (JP) | 1981-06-02 | — | — | US | disclosed |
| US-4166131-A | ANTIINFLAMMATORY AGENTS, ANTIPYRETICS, ANTIARTHRITIC AGENT | HEXACHIMIE SOCIETE ANONYME (FR) | 1979-08-28 | — | — | US | disclosed |
| US-4163108-A | ANTICOAGULANTS | LEVER BROTHERS COMPANY (US) | 1979-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260027108-A1 | PHARMACEUTICAL COMPOSITION OF HETEROARYL DERIVATIVE AND MEDICAL USE THEREOF | CYP2D6, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CYP2B6 | POLB 2676/4885ALDH1A1 2878/4885TSHR 1516/4885 |
| US-12491185-B2 | Inhibitors of mPTP | PARK7, PINK1, SNCA | POLB 3453/4885ALDH1A1 415/4885TSHR 3821/4885 |
| US-12606555-B2 | Chemical compounds | PARP1, PARP11, PARP12 | POLB 38/4885ALDH1A1 438/4885TSHR 4191/4885 |
| US-20260007672-A1 | INHIBITORS OF MPTP | PARK7, SNCA, CYC1 | POLB 2624/4885ALDH1A1 176/4885TSHR 3311/4885 |
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | CBR1, CBR3, TAS2R1 | POLB 1910/4885ALDH1A1 804/4885TSHR 1119/4885 |
| US-20260055104-A1 | CRYSTAL FORM OF HETEROARYL DERIVATIVE PARP INHIBITOR AND USE THEREOF | PARP1, PARP2, PARP3 | POLB 227/4885ALDH1A1 1118/4885TSHR 3348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.